Christine Roth

Christine Roth is a global pharmaceutical executive recognized for building high-performing teams, advancing breakthrough innovation, and leading with a clear sense of purpose. As a member of Bayer’s Pharmaceuticals Leadership Team, she plays a central role in shaping a more agile, product- and customer-centric organization – ensuring that scientific innovation is translated into meaningful outcomes for patients.

Since joining Bayer in 2022, Christine has been a key force in advancing the company’s mission of “Health for all, Hunger for none,” embedding purpose into strategy, culture, and execution. She focuses on enabling teams to operate with accountability, alignment, and speed – ensuring that transformative medicines reach patients more efficiently.

With more than 30 years of experience at Bristol Myers Squibb, GSK, Novartis, and Bayer, Christine brings a proven ability to navigate complex scientific and commercial environments while delivering sustained growth and innovation. She has led the development and launch of multiple first and best in class therapies, particularly in oncology, and brings additional depth in cardiovascular, metabolic, and infectious diseases.

Christine also serves on the boards of Vividion Therapeutics and Faron Pharmaceuticals, contributing her strategic insight to advance next generation therapies.